<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PONE-D-11-07307</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0022413</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Developmental biology</subject>
            <subj-group>
              <subject>Cell fate determination</subject>
              <subject>Molecular development</subject>
              <subject>Stem cells</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Epigenetics</subject>
              <subject>Gene expression</subject>
              <subject>Gene function</subject>
              <subject>Gene networks</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Model organisms</subject>
            <subj-group>
              <subject>Animal models</subject>
              <subj-group>
                <subject>Mouse</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Molecular cell biology</subject>
            <subj-group>
              <subject>Gene expression</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Genetics and Genomics</subject>
          <subject>Molecular Biology</subject>
          <subject>Developmental Biology</subject>
        </subj-group>
      </article-categories><title-group><article-title>Stage-Specific Germ-Cell Marker Genes Are Expressed in All Mouse Pluripotent Cell Types and Emerge Early during Induced Pluripotency</article-title><alt-title alt-title-type="running-head">Germ-Cell Markers in Pluripotent Cells</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Xu</surname>
            <given-names>Xingbo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Pantakani</surname>
            <given-names>D. V. Krishna</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Lührig</surname>
            <given-names>Sandra</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Tan</surname>
            <given-names>Xiaoying</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Khromov</surname>
            <given-names>Tatjana</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Nolte</surname>
            <given-names>Jessica</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Dressel</surname>
            <given-names>Ralf</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Zechner</surname>
            <given-names>Ulrich</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Engel</surname>
            <given-names>Wolfgang</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1"><label>1</label><addr-line>Institute of Human Genetics, University of Goettingen, Goettingen, Germany</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Department of Cellular and Molecular Immunology, University of Goettingen, Goettingen, Germany</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Institute of Human Genetics, University of Mainz, Mainz, Germany</addr-line>       </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Abdelhay</surname>
            <given-names>Eliana Saul Furquim Werneck</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">Instituto Nacional de Câncer, Brazil</aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">krishna.if1@gmail.com</email> (DVKP); <email xlink:type="simple">wengel@gwdg.de</email> (WE)</corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: XX DVKP WE. Performed the experiments: XX SL XT TK JN RD. Analyzed the data: DVKP RD UZ. Contributed reagents/materials/analysis tools: WE. Wrote the paper: XX DVKP UZ.</p>
        </fn>
      <fn fn-type="conflict">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="collection">
        <year>2011</year>
      </pub-date><pub-date pub-type="epub">
        <day>25</day>
        <month>7</month>
        <year>2011</year>
      </pub-date><volume>6</volume><issue>7</issue><elocation-id>e22413</elocation-id><history>
        <date date-type="received">
          <day>28</day>
          <month>4</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>6</month>
          <year>2011</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2011</copyright-year><copyright-holder>Xu et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
        <p>Embryonic stem cells (ESCs) generated from the <italic>in-vitro</italic> culture of blastocyst stage embryos are known as equivalent to blastocyst inner cell mass (ICM) <italic>in-vivo</italic>. Though several reports have shown the expression of germ cell/pre-meiotic (GC/PrM) markers in ESCs, their functional relevance for the pluripotency and germ line commitment are largely unknown. In the present study, we used mouse as a model system and systematically analyzed the RNA and protein expression of GC/PrM markers in ESCs and found them to be comparable to the expression of cultured pluripotent cells originated from the germ line. Further, siRNA knockdown experiments have demonstrated the parallel maintenance and independence of pluripotent and GC/PrM networks in ESCs. Through chromatin immunoprecipitation experiments, we observed that pluripotent cells exhibit active chromatin states at GC marker genes and a bivalent chromatin structure at PrM marker genes. Moreover, gene expression analysis during the time course of iPS cells generation revealed that the expression of GC markers precedes pluripotency markers. Collectively, through our observations we hypothesize that the chromatin state and the expression of GC/PrM markers might indicate molecular parallels between <italic>in-vivo</italic> germ cell specification and pluripotent stem cell generation.</p>
      </abstract><funding-group><funding-statement>This work was partly supported by the German Research Foundation (Deutsche Forschungsgemeinschaft) DFG SPP1356 (EN 84/22-1; ZE 442/4-1) and DFG FOR 1041 (EN 84/23-1; ZE 442/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
        <page-count count="11"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>The capacity of long-term self-renewal and the unique ability to differentiate into all three germ layer cell types (ectoderm, endoderm and mesoderm) define pluripotency. According to the source of cells used for the establishment of pluripotent cells, one can currently distinguish between the following pluripotent cell lines: (1) embryonic stem cells (ESCs) derived from the inner cell mass of mouse blastocysts at embryonic day 3.5 (E3.5) <xref ref-type="bibr" rid="pone.0022413-Evans1">[1]</xref>, <xref ref-type="bibr" rid="pone.0022413-Martin1">[2]</xref>, (2) embryonic germ cells (EGCs) cultured from primordial germ cells (PGCs) that colonize the genital ridge at E12.5 <xref ref-type="bibr" rid="pone.0022413-Matsui1">[3]</xref>, <xref ref-type="bibr" rid="pone.0022413-Resnick1">[4]</xref>, (3) embryonal carcinoma cells (ECCs) isolated from germ-cell tumors of either testis or ovary <xref ref-type="bibr" rid="pone.0022413-Kahan1">[5]</xref>, (4) germ line stem cells isolated from mouse neonatal and adult testis (GSCs and maGSCs, respectively) <xref ref-type="bibr" rid="pone.0022413-Guan1">[6]</xref>, <xref ref-type="bibr" rid="pone.0022413-KanatsuShinohara1">[7]</xref> and (5) induced pluripotent stem cells (iPSCs), derived from reprogramming somatic cells by ectopic expression of defined transcription factors <xref ref-type="bibr" rid="pone.0022413-Takahashi1">[8]</xref>. All the above mentioned cultured pluripotent cell lines (EGCs, ECCs, GSCs, and maGSCs) have a germ-cell origin, except ESCs, whose origin is not clearly understood. Although these cell lines have different molecular profiles mostly due to their developmental stage of isolation, they share the expression of germ cell/pre-meiotic (GC/PrM) markers that may indicate a germ-cell origin <xref ref-type="bibr" rid="pone.0022413-Zwaka1">[9]</xref>.</p>
      <p>During embryonic development, the specification of PGCs is crucial for the development of the germ line, which is finally destined to give rise to the totipotent zygote upon fertilization. Prior to gastrulation, the precursors of primordial germ cells arise in the E6.25 proximal epiblast from 4–8 cells positive for the transcriptional repressor Blimp1 <xref ref-type="bibr" rid="pone.0022413-Ohinata1">[10]</xref>, <xref ref-type="bibr" rid="pone.0022413-Saiti1">[11]</xref>. These Blimp1-positive cells continuously proliferate and start to express other PGC markers such as Fragilis and Stella by E7.5. Thereafter, PGCs initiate migration and colonization of the genital ridge and increase their number to approximately 4000 by E12.5 <xref ref-type="bibr" rid="pone.0022413-Saitou1">[12]</xref>, <xref ref-type="bibr" rid="pone.0022413-Sato1">[13]</xref>. Further development of PGC/germ cells to mature spermatozoa or oocytes depends on the coordinated genetic and epigenetic events <xref ref-type="bibr" rid="pone.0022413-Bowles1">[14]</xref>. Interestingly, several studies have demonstrated the expression of some of the GC/PrM markers like Blimp1, Stella, Fragilis, Piwil2, Dazl and MVH in ES cells at the RNA level <xref ref-type="bibr" rid="pone.0022413-Geijsen1">[15]</xref>, <xref ref-type="bibr" rid="pone.0022413-Mise1">[16]</xref>, <xref ref-type="bibr" rid="pone.0022413-Qing1">[17]</xref>, raising the possibility that ES cells might originate from the germ line <xref ref-type="bibr" rid="pone.0022413-Zwaka1">[9]</xref>.</p>
      <p>In the present study, using mouse as a model system, we have systematically analyzed the expression of GC/PrM markers in ES cells compared to germ line origin cultured pluripotent cells like EGCs, ECCs, GSCs and maGSCs and found comparable expression at the RNA and protein level. Moreover, we show the expression of Stella, Dazl and MVH in preimplantation embryos and, the independence of pluripotency-specific networks from germ cell-specific networks in ES cells. Interestingly, chromatin immunoprecipitation (ChIP) analysis revealed that ES cells exhibit active chromatin states at GC marker genes and a bivalent chromatin structure at PrM marker genes. Further, gene expression analysis during iPSC generation revealed that the expression of GC markers precedes pluripotency markers. Collectively, our data indicates the possible link between <italic>in-vivo</italic> germ cells specification and <italic>in-vitro</italic> pluripotent stem cells generation.</p>
    </sec>
    <sec id="s2" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec id="s2a">
        <title>Cell culture</title>
        <p>Derivation and maintenance of male mouse ESC and maGSC lines from different genetic backgrounds (129Sv and C57BL/6) were described previously <xref ref-type="bibr" rid="pone.0022413-Zechner1">[18]</xref>. The female ESC line ES Rosa26 was generated from Rosa26-LacZ transgenic mouse line as described for MPI-VI, a previously generated female ESC line <xref ref-type="bibr" rid="pone.0022413-Voss1">[19]</xref>. iPS cells (O18) were a kind gift from Prof. Rudolf Jaenisch <xref ref-type="bibr" rid="pone.0022413-Wernig1">[20]</xref>. All above cell lines including EGC line (EG 1) and parthenogenetic cells were maintained in standard ESC culture conditions. ECC cell line (F9) protein extract was provided by Mr. Peter Christalla, Goettingen. For knockdown experiments, ES cells were seeded in KO-DMEM supplemented with KO-serum replacement (Invitrogen) at a density of 2×10<sup>5</sup> cells/ml on feeder layer. After 5 h of plating, the cells were transfected with either <italic>Dazl</italic> siRNA (NM_010021.4_stealth_199, _726, _1056, Invitrogen) or <italic>MVH</italic> siRNA (NM_001145885.1_stealth_83, _922, _1599, Invitrogen) or <italic>Oct3/4</italic> siRNA (NM_013633_Stealth_356, _463, _727, Invitrogen) or scrambled siRNA (Control siRNA, Invitrogen) using Lipofectamine-2000 (Invitrogen) according to manufacturer's instructions. After 3 h of transfection, the medium was changed to standard ES culture medium and allowed to grow for 24 h. The next day, transfection was repeated and cells were harvested after additional 24 h of culture.</p>
        <p>All animal experimentations were reviewed and approved by the Institutional Animal Care and Use committee of the University of Goettingen (Approval ID: 33.9.42502-097/06).</p>
      </sec>
      <sec id="s2b">
        <title>Generation of iPS cells</title>
        <p>We used Yamanaka factors (retroviral expression vectors for Oct3/4, Sox2, Klf4, c-Myc) to generate iPS cells <xref ref-type="bibr" rid="pone.0022413-Takahashi1">[8]</xref>. For reprogramming studies, embryonic fibroblasts isolated from transgenic <italic>Nanog</italic>-EGFP mice <xref ref-type="bibr" rid="pone.0022413-Okita1">[21]</xref> were transduced with retroviral particles as previously described <xref ref-type="bibr" rid="pone.0022413-Takahashi1">[8]</xref>. To establish iPS cell lines, colonies which appeared after 10 days of virus infection were picked manually and cultured in 24-well plates containing feeder layer with standard ES medium and were monitored for the <italic>Nanog</italic>-EGFP activation using invert microscope (Olympus). For time course experiments, all cells from culture plates were collected on days 0 (Control), 5-10, 12, 14, 16, 18, 20 and 22 after viral infection for total RNA isolation.</p>
      </sec>
      <sec id="s2c">
        <title>RNA extraction, RT-PCR and qPCR</title>
        <p>Total RNA was extracted from cells using Trizol Reagent (Invitrogen) and from ∼50 blastocysts using Picopure Kit (Analytical Technology) following the manufacturers' protocols. Total RNA from blastocysts or 5 µg of total RNA from cells was digested with <italic>DNaseI</italic> (Sigma) and used for cDNA synthesis using the SuperScriptII system (Invitrogen). For qPCR analysis, diluted cDNA (1/20) was used as a template in a Platinum SYBR Green qPCR SuperMix-UDG with ROX (Invitrogen) and run in ABI 7900HT Real-Time PCR System (Applied Biosystems). Primers used in RT-PCR and qPCR are listed in supplementary tables (<xref ref-type="supplementary-material" rid="pone.0022413.s004">Tables S1</xref>, <xref ref-type="supplementary-material" rid="pone.0022413.s005">S2</xref>, <xref ref-type="supplementary-material" rid="pone.0022413.s006">S3</xref>).</p>
      </sec>
      <sec id="s2d">
        <title>Protein extraction and Western blotting</title>
        <p>Proteins were extracted from cells and tissues using lysis buffer (10 mM Tris–HCl (pH 8.0), 1 mM EDTA, 2.5% SDS, 100 mM PMSF) containing protease inhibitor cocktail (Roche). Protein samples were resolved on 4–12% SDS-PAGE and transferred onto nitrocellulose membrane (Amersham Biosciences). Membranes were processed using standard Western blot protocols, and signals detected using a chemiluminescent kit (Santa Cruz Biotechnology). Antibody sources are listed in supplementary tables (<xref ref-type="supplementary-material" rid="pone.0022413.s008">Table S5</xref>).</p>
      </sec>
      <sec id="s2e">
        <title>Early-stage-embryo collection, immunocytochemistry, and alkaline phosphatase staining</title>
        <p>Early stage embryos collected from the oviduct or uterus of pregnant CD-1 mice were used for whole-mount immunostaining as described previously <xref ref-type="bibr" rid="pone.0022413-Chazaud1">[22]</xref>. Immunostained embryos were mounted on cavity microscope slides using Vectashield DAPI mounting medium (Vector Laboratories) and images were acquired using an Olympus confocal microscope. Immunostaining on iPS cells using SSEA1 antibody was performed as previously described <xref ref-type="bibr" rid="pone.0022413-Khromov1">[23]</xref>. Alkaline phosphatase <bold>(</bold>AP) staining was performed according to manufacturer's protocol (Sigma).</p>
      </sec>
      <sec id="s2f">
        <title>Chromatin immunoprecipitation</title>
        <p>The chromatin immunoprecipitation (ChIP) was performed essentially as previously described <xref ref-type="bibr" rid="pone.0022413-Khromov1">[23]</xref>. Briefly, cultured wild-type ESCs were cross-linked with 1% formaldehyde and briefly incubated in lysis buffer followed by sonication (Branson Sonifier 250). Soluble chromatin was pre-cleared with protein-A sepharose beads and incubated with and without (negative-control) antisera (3–5 µg) directed against H3K4me3, H3K9ac, H3K9me3, and H3K27me3. Enriched DNA was analyzed by qPCR using SYBR green (Invitrogen)-based PCR amplification with primers listed in supplementary tables (<xref ref-type="supplementary-material" rid="pone.0022413.s007">Table S4</xref>). qPCR data from two or more biological replicates were calculated and expressed as percentage of input DNA precipitation. Antibodies used in ChIP are listed in supplementary tables (<xref ref-type="supplementary-material" rid="pone.0022413.s008">Table S5</xref>).</p>
      </sec>
      <sec id="s2g">
        <title>Teratoma formation assay</title>
        <p>Teratoma formation assay was performed as previously described <xref ref-type="bibr" rid="pone.0022413-Dressel1">[24]</xref>, <xref ref-type="bibr" rid="pone.0022413-Dressel2">[25]</xref>. Briefly, iPS cells (1×10<sup>6</sup> cells) were injected subcutaneously into 8 to 10 weeks old female severe combined immunodeficient RAG2<sup>−/−</sup>cγc<sup>−/−</sup> mice lacking T, B, and natural killer (NK) cells. Tumor growth was monitored weekly by palpation and size was recorded using linear calipers. Animals were sacrificed when a tumor diameter of 1 cm was reached. Autopsies were performed and tumor tissue was placed in phosphate-buffered 4% formalin for 16 h and then embedded in paraffin. For histological analysis, the specimens were stained with haematoxylin and eosin (HE).</p>
      </sec>
      <sec id="s2h">
        <title>Statistical Analysis</title>
        <p>All qPCR data for RNA expression analysis (two or more biological replicates) were calculated using standard curve method. For statistical significance calculations, 2way ANOVA (GraphPad Prism 4.0) test was used.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <sec id="s3a">
        <title>Pluripotent stem cells express GC/PrM genes</title>
        <p>To investigate whether GC/PrM gene expression is characteristic of all known mouse pluripotent cells, we systematically analyzed several pluripotent cells. Firstly, we examined GC/PrM gene expression in male maGSCs and ESCs from different genetic backgrounds and in iPSCs, EGCs, and F9 cells by Western blotting (<xref ref-type="fig" rid="pone-0022413-g001">Fig. 1A</xref>). GC markers Stella and Fragilis were readily detected in all cell types (<xref ref-type="fig" rid="pone-0022413-g001">Fig. 1A</xref>), including parthenogenetic cells (<xref ref-type="fig" rid="pone-0022413-g001">Fig. 1B</xref>). Further, PrM markers Piwil2, Dazl, and MVH were found to be expressed in all pluripotent cells, except ECCs (<xref ref-type="fig" rid="pone-0022413-g001">Fig. 1A</xref>). Protein levels of GC/PrM markers were reduced or absent in ESCs and maGSCs upon spontaneous differentiation with retinoic acid for 20 days (<xref ref-type="fig" rid="pone-0022413-g001">Fig. 1B</xref>). Overmore, we analyzed multipotent mesenchymal stem cells (MSCs) and could not detect any expression of GC/PrM markers (<xref ref-type="fig" rid="pone-0022413-g001">Fig. 1B</xref>). We also performed RT-PCR analysis for other PrM, meiotic, and post-meiotic markers (<xref ref-type="fig" rid="pone-0022413-g001">Fig. 1C</xref>). Expression of PrM markers <italic>Stra8</italic>, <italic>Rnf17</italic>, <italic>Rnh2</italic>, and <italic>Piwil2</italic> was detected in all cells (<xref ref-type="fig" rid="pone-0022413-g001">Fig. 1C</xref>). Surprisingly, meiotic markers <italic>Sycp3</italic>, <italic>Pgk2</italic>, and <italic>Creb3/4</italic> were also detected in all pluripotent cell lines (<xref ref-type="fig" rid="pone-0022413-g001">Fig. 1C</xref>). However, expression of several other developmental markers such as post-meiotically expressed <italic>Tp2</italic>, <italic>Theg</italic>, <italic>Gpx4</italic>, <italic>Prm1</italic>, and mature spermatozoan marker <italic>Cylc1</italic> was undetectable as expected (<xref ref-type="fig" rid="pone-0022413-g001">Fig. 1C</xref>).</p>
        <fig id="pone-0022413-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0022413.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Expression analysis of GC/PrM genes in pluripotent cell lines.</title>
            <p>(<bold>A</bold>) Expression of GC markers (Stella, Fragilis) and PrM markers (Piwil2, Dazl, MVH) in maGSCs and ESCs (of 129Sv and C57BL/6 genetic backgrounds), iPSCs, EGCs and ECCs<bold>.</bold> (<bold>B</bold>) Western blot of GC marker (Stella) and PrM markers (Dazl and MVH) in mouse mesenchymal stromal cells (MSC), parthenogenetic cells, ES and maGSC treated with retinoic acid for 20 days. Protein extract from ESCs was used as a positive control. (<bold>C</bold>) RT-PCR analysis showing the expression of PrM (<italic>Stra8</italic>, <italic>Rnf17</italic>, <italic>Rnh2</italic> and <italic>Piwil2</italic>), meiotic (<italic>Sycp3</italic>, <italic>Pgk2</italic> and <italic>Creb3/4</italic>) and post-meiotic (<italic>Tp2</italic>, <italic>Prm1</italic> and <italic>Cylc1</italic>) markers in maGSC and ESC (from different genetic backgrounds), as well as iPSC, EGC and ECC cell lines. cDNA from wild type mouse testis and lung were used as positive and negative controls, respectively. (<bold>D</bold>) Western blot analysis showing the expression of GC markers (Stella, Fragilis), PrM markers (Dmc1, Dazl, MVH) in two different female ESC lines (MPI VI, ES Rosa26). α-tubulin was used as loading control in <bold>A, B and D</bold>.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.g001" xlink:type="simple"/>
        </fig>
        <p>To determine whether the expression of GC/PrM markers is specific to male pluripotent cells, we studied two female ES cell lines, namely, MPI VI and ES Rosa26. Pluripotency of these cell lines was confirmed by detecting the expression of the key pluripotency markers Oct3/4 and Sox2 (data not shown). Both female pluripotent cell lines were found to express all analyzed GC/PrM markers with levels similar to those of male pluripotent cells (<xref ref-type="fig" rid="pone-0022413-g001">Fig. 1D</xref>).</p>
      </sec>
      <sec id="s3b">
        <title>GC/PrM genes are also expressed in early embryogenesis</title>
        <p>Next, we studied the expression of GC marker (Stella) and PrM markers (Dazl and MVH) in early stages of mouse embryogenesis (2-, 4-, 8-cell stages) by immunocytochemistry (ICC) (<xref ref-type="fig" rid="pone-0022413-g002">Fig. 2A</xref>). Interestingly, we found Stella, Dazl and MVH to be expressed throughout all stages of embryogenesis (<xref ref-type="fig" rid="pone-0022413-g002">Fig. 2A</xref>). To determine the expression levels of GC/PrM markers at the blastocyst stage, we performed qPCR on blastocyst stage embryos (<xref ref-type="fig" rid="pone-0022413-g002">Fig. 2B</xref>). In agreement with our ICC results, all analyzed GC/PrM markers (<italic>Fragilis</italic>, <italic>Dazl</italic>, <italic>MVH</italic>, and <italic>Stra8</italic>) were detected at the blastocyst stage with transcript levels, that are, however, markedly lower than those of pluripotency markers such as <italic>Oct3/4</italic>, <italic>Nanog</italic>, <italic>Lin28</italic> (<xref ref-type="fig" rid="pone-0022413-g002">Fig. 2B</xref>).</p>
        <fig id="pone-0022413-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0022413.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Expression analysis of GC/PrM genes in early embryogenesis.</title>
            <p>(<bold>A</bold>) Immunocytochemistry showing the expression of GC marker (Stella) and PrM markers (Dazl and MVH) in pre-implantation embryos (2-cell, 4-cell, and 8-cell stage). DAPI was used as a counter stain to visualize the nucleus. (<bold>B</bold>) Quantitative real time PCR analysis was used to evaluate the expression levels of GC (Fragilis), PrM (Dazl, MVH, Stra8) and pluripotency markes (Oct3/4, Nanog, Lin28) in blastocysts. Expression levels were normalized to <italic>Sdha</italic> (a house keeping gene). The qPCR data of three biological replicates (including three technical replicates each) were calculated and represented as a mean ±SD.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.g002" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s3c">
        <title>Independency of pluripotent and GC/PrM networks in ESCs</title>
        <p>The widespread expression of GC/PrM markers in pluripotent cells led us to study their influence on other GC/PrM and key pluripotency markers (<xref ref-type="fig" rid="pone-0022413-g003">Fig. 3</xref>). Firstly, we down-regulated <italic>Dazl</italic> in ES cells using siRNA and found an ∼80–90% decrease at both the RNA and protein level (<xref ref-type="fig" rid="pone-0022413-g003">Fig. 3A, B</xref>). In contrast, control siRNA treated cells did not exhibit altered Dazl expression levels (<xref ref-type="fig" rid="pone-0022413-g003">Fig. 3A, B</xref>). Then, we performed a qPCR-based analysis of expression levels of key pluripotency markers and detected no significant differences among control siRNA treated and Dazl siRNA treated cells (<xref ref-type="fig" rid="pone-0022413-g003">Fig. 3C</xref>). Similarly, the expression of PrM markers <italic>MVH</italic> and <italic>Stra8</italic> did not change significantly, whereas GC markers (<italic>Stella</italic> and <italic>Fragilis</italic>) showed significant up-regulation in Dazl down-regulated cells (<xref ref-type="fig" rid="pone-0022413-g003">Fig. 3D</xref>). Similarly, ∼70% down-regulation of <italic>MVH</italic> expression (<xref ref-type="fig" rid="pone-0022413-g003">Fig. 3E, F</xref>) did not influence expression of key pluripotency markers (<xref ref-type="fig" rid="pone-0022413-g003">Fig. 3G</xref>). Consistent with Dazl down-regulation, MVH depletion had no effect on <italic>Dazl</italic> and <italic>Stra8</italic>, but <italic>Stella</italic> and <italic>Fragilis</italic> were significantly up-regulated (<xref ref-type="fig" rid="pone-0022413-g003">Fig. 3H</xref>). Conversely, we down-regulated <italic>Oct3/4</italic> and studied the expression of GC/PrM and pluripotency markers. The down-regulation of <italic>Oct3/4</italic> resulted in significant down-regulation of <italic>Klf4</italic> expression, whereas the expression of other pluripotent markers such as <italic>Nanog</italic>, <italic>Zfp206</italic>, and <italic>Lin28</italic> did not alter (Supplementary <xref ref-type="supplementary-material" rid="pone.0022413.s001">Fig. S1</xref>). Furthermore, the down-regulation of <italic>Oct3/4</italic> had no statistically significant effect on the expression of GC/PrM markers (Supplementary <xref ref-type="supplementary-material" rid="pone.0022413.s001">Fig. S1</xref>).</p>
        <fig id="pone-0022413-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0022413.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Effect of the downregulation of PrM genes in ESCs.</title>
            <p>(<bold>A and B</bold>) Efficiency of Dazl down-regulation as shown by Western blot analysis and subsequent densitometric qunatification<bold>.</bold> (<bold>C</bold>) Real time qPCR analysis showing <italic>Dazl</italic> downregulation at the RNA level and the expression profile of the core pluripotency network (<italic>Oct3/4</italic>, <italic>Klf4</italic>, <italic>Nanog</italic>, <italic>Zfp206</italic> and <italic>Lin28</italic>). (<bold>D</bold>) Expression of GC (<italic>Stella</italic> and <italic>Fragilis</italic>) and PrM (<italic>MVH</italic> and <italic>Stra8</italic>) markers in <italic>Dazl</italic> down-regulated ESCs. (<bold>E and F</bold>) Western blot showing the efficiency of MVH downregulation and the densitometric quantification, respectively. (<bold>G</bold>) Real time qPCR analysis showing <italic>MVH</italic> downregulation at the RNA level and the expression profile of the core pluripotency network (<italic>Oct3/4</italic>, <italic>Klf4</italic>, <italic>Nanog</italic>, <italic>Zfp206</italic> and <italic>Lin28</italic>). (<bold>H</bold>) Expression of GC (<italic>Stella</italic> and <italic>Fragilis</italic>) and PrM (<italic>Dazl</italic> and <italic>Stra8</italic>) markers in <italic>MVH</italic> down-regulated ESCs. The dotted lines in <bold>C</bold>, <bold>D</bold>, <bold>G</bold>, <bold>H</bold> indicate the normalized expression levels of analyzed genes in control siRNA treated cells. The qPCR data of two biological replicates (including three technical replicates each) were calculated and represented as a mean ±SD. Expression levels, which are statistically significant, are indicated with asterisks (**p&lt;0.01; ***p&lt;0.001).</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.g003" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s3d">
        <title>Active chromatin at GC marker gene promoter regions and bivalent chromatin at PrM marker gene promoters in ESCs and iPSCs</title>
        <p>We hypothesized that the chromatin state at the promoter regions of GC/PrM markers might elucidate their role in the establishment/maintenance of pluripotency or lineage specification in ESCs. We analyzed the ChIP sequencing data of mouse ES cells, which is freely available <xref ref-type="bibr" rid="pone.0022413-Mikkelsen1">[26]</xref> and found that the promoter regions of GC markers <italic>Blimp1</italic>, <italic>Stella</italic> and <italic>Fragilis</italic> were enriched for H3K4me3 indicating the transcriptionally active chromatin state, as seen for <italic>Oct3/4</italic> (Supplementary <xref ref-type="supplementary-material" rid="pone.0022413.s002">Fig. S2A</xref>). In contrast the promoter regions of <italic>Dazl</italic> and <italic>MVH</italic> were decorated with both H3K4me3 and H3K27me3, highlighting the bivalent chromatin state, which is a hall mark of lineage specification genes, such as <italic>Hoxa11</italic> and <italic>Pax5</italic> (Supplementary <xref ref-type="supplementary-material" rid="pone.0022413.s002">Fig. S2B</xref>). To further validate these observations, gene specific histone modification profiles (active: H3K4me3, H3K9ac; and repressive: H3K9me3, H3K27me3) were analyzed by ChIP at the promoter regions of GC markers <italic>Fragilis</italic> and <italic>Blimp1</italic>, and PrM markers <italic>Dazl</italic> and <italic>MVH</italic>, and compared to the promoter regions of <italic>Oct3/4</italic> (transcriptionally active chromatin) and <italic>Hoxa11</italic> and <italic>Pax5</italic> (bivalent chromatin) in ES cells (<xref ref-type="fig" rid="pone-0022413-g004">Fig. 4A</xref>). qPCR quantification of ChIP DNA showed that the promoter regions of GC markers <italic>Fragilis</italic> and <italic>Blimp1</italic> were enriched for the activating modifications H3K4me3 and H3K9ac, but depleted for the repressive modifications H3K9me3 and H3K27me3, indicating a transcriptionally active chromatin similar to key pluripotency <italic>Oct3/4</italic> gene promoter (<xref ref-type="fig" rid="pone-0022413-g004">Fig. 4A</xref>). In contrast, the promoters of PrM genes <italic>Dazl</italic> and <italic>MVH</italic> were enriched for both active (H3K4me3 and H3K9ac) and repressive (H3K27me3) modifications, representing the bivalent chromatin domain similar to lineage specific genes (<italic>Hoxa11</italic> and <italic>Pax5</italic>) (<xref ref-type="fig" rid="pone-0022413-g004">Fig. 4A</xref>). Moreover, we also performed gene specific histone modification profiling in established iPS cells <xref ref-type="bibr" rid="pone.0022413-Wernig1">[20]</xref> and found similar results like ES cells (<xref ref-type="fig" rid="pone-0022413-g004">Fig. 4B</xref>).</p>
        <fig id="pone-0022413-g004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0022413.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>Epigenetic signature of GC/PrM genes in ESCs and iPSCs.</title>
            <p>ChIP and subsequent real time qPCR for various histone modifications (active: H3K4me3 and H3K9ac; repressive: H3K9me3 and H3K27me3) at the promoter regions of GC (<italic>Fragilis</italic> and <italic>Blimp1</italic>) and PrM markers (<italic>Dazl</italic> and <italic>MVH</italic>) in ESCs (<bold>A</bold>) and iPSCs (<bold>B</bold>). The promoter regions of GC markers are similar to the <italic>Oct3/4</italic> promoter and are enriched for active histone modifications, while the promoters of PrM markers are similar to the promoters of the lineage specific genes <italic>Hoxa11</italic>, <italic>Pax5</italic> and were enriched for both active and repressive marks indicating their bivalent chromatin structure. The qPCR data of two biological replicates (including three technical replicates each) were calculated and represented as a mean ±SD.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.g004" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s3e">
        <title>GC markers emerge during early reprogramming of MEFs into iPSCs</title>
        <p>To further understand the role of GC/PrM markers during the establishment and maintenance of pluripotency, we used ectopic expression of the four Yamanaka factors (Oct4, c-Myc, Klf4, and Sox2) for reprogramming of somatic cells to induced pluripotency. Firstly, we reprogrammed MEFs isolated from Nanog-EGFP mice and established four iPS lines (xu1, 2, 5, and 6), which are morphologically similar to ES cells, activate the <italic>Nanog</italic> promoter-driven EGFP expression, positive for AP staining, SSEA1 immunostaining and express endogenous Oct3/4 and Sox2 (<xref ref-type="fig" rid="pone-0022413-g005">Fig. 5A–D</xref>). The iPSC lines were further characterized by histone modification, and DNA methylation profiling of key pluripotent marker genes (data not shown). Finally, all the iPSC lines (xu1, 2, 5 and 6) were injected subcutaneously into immunodeficient mice. Two recipients were used per cell line. In all mice, tumors were observed and the mice had to be sacrificed between day 18 and day 33 after injection. The tumors were identified as teratomas by histological examination as exemplified for iPS cell lines xu2 and 6 (Supplementary <xref ref-type="supplementary-material" rid="pone.0022413.s003">Fig. S3</xref>). Then, we setup a time course experiment and analyzed the expression levels of key pluripotency genes and GC/PrM genes during the course of reprogramming as outlined in <xref ref-type="fig" rid="pone-0022413-g005">figure 5E</xref>. Expression analysis using real time qPCR revealed significant expression levels of key germ cell markers (<italic>Blimp1</italic> and <italic>Fragilis</italic>) at day 6 and a gradual increase to the levels seen in ES cells by day 22 (<xref ref-type="fig" rid="pone-0022413-g005">Fig. 5F, G</xref>). Transcripts of <italic>Stella</italic>, another germ cell marker, were significantly detectable at day 10 of reprogramming and reached levels similar to those in ES cells by day 22. (<xref ref-type="fig" rid="pone-0022413-g005">Fig. 5F, G</xref>). In contrast, significant endogenous expression levels of the key pluripotency markers <italic>Oct3/4</italic> and <italic>Sox2</italic> occurred only on day 12 of reprogramming and showed expression levels typical for ES cells by day 22 (<xref ref-type="fig" rid="pone-0022413-g005">Fig. 5G</xref>). Further pluripotency markers like <italic>Zfp206</italic> and <italic>Nanog</italic> appeared only on day 18 and 20, respectively and increased to levels observed in ES cells only in fully reprogrammed and established iPS cells (<xref ref-type="fig" rid="pone-0022413-g005">Fig. 5G</xref>). Surprisingly, we could not detect significant expression of pre-meiotic markers such as <italic>Stra8</italic>, <italic>Dazl</italic> and <italic>MVH</italic> before day 22 of reprogramming. The expression of <italic>Stra8</italic> appeared not until day 22 and the other two markers were only present in established iPS cells (<xref ref-type="fig" rid="pone-0022413-g005">Fig. 5G</xref>).</p>
        <fig id="pone-0022413-g005" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0022413.g005</object-id>
          <label>Figure 5</label>
          <caption>
            <title>Expression pattern of GC/PrM and pluripotency genes during the course of iPS generation.</title>
            <p>Fully reprogrammed and established iPS cells express <italic>Nanog</italic> promoter-driven EGFP (<bold>A</bold>), positive for AP staining (<bold>B</bold>), and express SSEA1 (<bold>C</bold>). (<bold>D</bold>) Expression of key pluripotency markers Oct3/4 and Sox2 in iPS cells. Protein extract from ESCs was used as a positive control. (<bold>E</bold>) Schematic diagram depicting the generation of iPS cells using the four Yamanaka factors and the time course of sample collection (starting from the day of retrovirus transduction, day0 (d0) till day22 (d22)) for gene expression analysis. (<bold>F</bold>) Real time qPCR analysis of pluripotency (<italic>Oct3/4</italic>, <italic>Sox2</italic>, <italic>Nanog</italic> and <italic>Zfp206</italic>), germ cell (<italic>Stella</italic>, <italic>Blimp1</italic> and <italic>Fragilis</italic>) and pre-meiotic genes (<italic>Dazl</italic>, <italic>MVH</italic> and <italic>Stra8</italic>) during the time course of iPS cell generation from day5 (5d) to day 10 (10d) after virus infection. <italic>Nanog</italic>-EGFP MEFs were used as a control. <bold>(G)</bold> Real time qPCR analysis for the above mentioned genes during the time course of iPS cell generation from day12 (12d) to day 22 (22d) after virus infection. The qPCR data of two or more biological replicates (including three technical replicates each) were calculated and represented as a mean ±SD.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.g005" xlink:type="simple"/>
        </fig>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>Though traditionally pluripotent ES cells are regarded as <italic>in-vitro</italic> counterpart of the inner cell mass (ICM), their origin is not yet clearly defined. Recently, it has been hypothesized that ESCs may have a germ-cell origin based on common molecular properties with other pluripotent cells of germ-cell origin <xref ref-type="bibr" rid="pone.0022413-Zwaka1">[9]</xref>. Previously, ES cells were shown to express several GC/PrM markers <xref ref-type="bibr" rid="pone.0022413-Geijsen1">[15]</xref>, <xref ref-type="bibr" rid="pone.0022413-Mise1">[16]</xref>, <xref ref-type="bibr" rid="pone.0022413-Qing1">[17]</xref>. In agreement with these results, that demonstrated the expression of several GC/PrM markers at the transcript level, our Western blot analysis detected the expression of GC/PrM markers in all analyzed pluripotent cell types available including iPS cells and female ES cells of mouse origin. Consistent with an earlier report <xref ref-type="bibr" rid="pone.0022413-Nayernia1">[27]</xref>, expression of GC/PrM genes was not detectable in bone marrow-derived multipotent stem cells, thus indicating the unique expression of GC/PrM genes only in pluripotent cells. Our immunocytochemistry expression analysis of GC/PrM markers in preimplantation embryos revealed the expression of Stella, Dazl and MVH in all analyzed preimplantation embryo stages (2-, 4-, 8-cell stage). Further, down-regulation of PrM genes in ESCs did not influence the expression levels of pluripotency network genes, but rather increase expression of GC genes. Conversely, down-regulation of pluripotency marker Oct3/4 showed no significant effect on GC/PrM marker genes, thus highlighting the maintenance of parallel but independent networks.</p>
      <p>The genome-wide expression profiling of ES cells revealed the expression of a large number of genes at low levels due to the open chromatin state of ES cells leading to leaky expression <xref ref-type="bibr" rid="pone.0022413-Carter1">[28]</xref>, <xref ref-type="bibr" rid="pone.0022413-Efroni1">[29]</xref>, <xref ref-type="bibr" rid="pone.0022413-Meshorer1">[30]</xref>, <xref ref-type="bibr" rid="pone.0022413-Roeder1">[31]</xref>. To elucidate leaky versus essential expression of GC/PrM markers in ES cells, we analyzed the global ChIP-Seq data of ES cells and found an active chromatin state at PGC/germ cell markers and a bivalent chromatin structure at pre-meiotic markers <xref ref-type="bibr" rid="pone.0022413-Mikkelsen1">[26]</xref>. In support of global ChIP-seq data, our gene-specific chromatin state of GC/PrM markers in ES cells confirmed the active chromatin state with enrichment for the activating histone modifications H3K4me3 and H3K9ac at the promoter regions of PGC markers <italic>Blimp1</italic> and <italic>Fragilis</italic>, which demonstrates the fundamental expression of these genes. In contrast, the promoter regions of <italic>Dazl</italic> and <italic>MVH</italic> were marked with bivalent chromatin state, i.e. enrichment for the two activating (H3K4me3 and H3K9ac) and the repressive (H3K27me3) histone modifications, which is a hallmark of key developmental regulation/lineage specific genes <xref ref-type="bibr" rid="pone.0022413-Azuara1">[32]</xref>, <xref ref-type="bibr" rid="pone.0022413-Bernstein1">[33]</xref>. The observed active chromatin state at GC marker genes might indicate the possible early germ cell specification epigenetic marks in pluripotent cells. Conversely, the bivalent chromatin state at PrM marker genes might represent the poised germ cell lineage specification or the heterogeneous expression of these genes in pluripotent cells.</p>
      <p>Recent advances in direct reprogramming of somatic cells to induced pluripotency opened new avenues not only for tailor-made patient-specific cells for future regenerative medicine in addition to advancing our knowledge of the basic biology of establishment and maintenance of pluripotency <xref ref-type="bibr" rid="pone.0022413-Cox1">[34]</xref>. Of particular interest is the role of GC/PrM markers during iPS cell generation using the four Yamanaka's factors. We analyzed the activation of GC/PrM markers along with the endogenous activation of core pluripotency markers during somatic reprogramming and found the activation of the PGC specification markers <italic>Blimp1</italic>, <italic>Stella</italic> and <italic>Fragilis</italic> to occur much earlier (between day 6 and day 9 of reprogramming) than activation of the endogenous pluripotency markers <italic>Oct3/4</italic> and <italic>Sox2</italic> (by day12 of reprogramming). In contrast, the expression of the PrM markers <italic>Dazl</italic>, <italic>MVH</italic> and <italic>Stra8</italic> was only detectable by day 22 and in established iPS cell lines, respectively. Recent studies of the molecular mechanisms underlying somatic reprogramming revealed that somatic cells undergo mesenchymal to epithelial transition (MET) during early reprogramming to acquire pluripotency through BMP signaling and vital expression of E-cadherin <xref ref-type="bibr" rid="pone.0022413-Li1">[35]</xref>, <xref ref-type="bibr" rid="pone.0022413-SamavarchiTehrani1">[36]</xref>. Interestingly, during embryonic development, PGC precursors rely on inductive BMP signals followed by MET activation and Fragilis, Blimp1, Stella and E-cadherin expression <xref ref-type="bibr" rid="pone.0022413-Matsui2">[37]</xref>, <xref ref-type="bibr" rid="pone.0022413-Saitou2">[38]</xref>. Loss of BMP signals, Blimp1 and E-cadherin expression results in the depletion or a reduced number of PGCs <xref ref-type="bibr" rid="pone.0022413-Saitou2">[38]</xref>, <xref ref-type="bibr" rid="pone.0022413-Lawson1">[39]</xref>, <xref ref-type="bibr" rid="pone.0022413-Okamura1">[40]</xref>, <xref ref-type="bibr" rid="pone.0022413-Ying1">[41]</xref>. Taken together, we assume that even somatic cells acquire a “temporary” PGC/GC fate and finally establish pluripotency during reprogramming.</p>
      <p>Based on our study and earlier reports <xref ref-type="bibr" rid="pone.0022413-Zwaka1">[9]</xref>, we propose a working model for the germ-cell origin of ESCs and the possible acquisition of PGC/GC fate by somatic cells during iPSCs generation (<xref ref-type="fig" rid="pone-0022413-g006">Fig. 6</xref>). According to our model, the ICM of blastocyst stage embryos (∼E3.5) expresses key pluripotency markers Oct3/4, Sox2, and c-Myc. Following embryonic development, PGC specification <italic>in-vivo</italic> is marked by the expression of key PGC genes, where Blimp1 is activated by BMP signaling <xref ref-type="bibr" rid="pone.0022413-Ohinata1">[10]</xref>, facilitates the activation of Stella and E-cadherin, initiates the repression of the somatic program, and reactivates the pluripotency network before PGCs acquire migratory properties <xref ref-type="bibr" rid="pone.0022413-Saitou2">[38]</xref> (<xref ref-type="fig" rid="pone-0022413-g006">Fig. 6A</xref>). Considering the GC fate and lineage commitment of PGCs, key germ-cell markers may have active chromatin, whereas PrM genes may show bivalent chromatin (<xref ref-type="fig" rid="pone-0022413-g006">Fig. 6C</xref>). Similarly, ESC generation also starts with isolation of ∼E3.5 blastocysts followed by culture to obtain outgrowth from the ICM. It is more likely that during the <italic>in-vitro</italic> ICM outgrowth, ICM cells proceed with the pre-programmed developmental program of PGC specification via BMP signals, initiate MET, begin expressing Fragilis, Blimp1, and Stella, re-activate pluripotency genes, and acquire the unique self-renewal property (<xref ref-type="fig" rid="pone-0022413-g006">Fig. 6A</xref>). The observed active chromatin state of <italic>Blimp1</italic>, <italic>Stella,</italic> and <italic>Fragilis</italic> thus might indicate the unique expression or PGC/GC origin of ESC and the bivalent chromatin state of <italic>Dazl</italic> and <italic>MVH</italic> confers the germ-cell lineage commitment, as has been observed for other lineages (<xref ref-type="fig" rid="pone-0022413-g006">Fig. 6C</xref>). Similarly, during somatic reprogramming, addition of Oct3/4, Sox2, c-Myc, and Klf4 to somatic cells might mimic the <italic>in-vivo</italic> ∼E3.5 blastocyst ICM cells and follows the induction of BMP signaling and hence the activation of Fragilis, Blimp1, Stella, and E-cadherin, and MET (<xref ref-type="fig" rid="pone-0022413-g006">Fig. 6B</xref>). Further, activation of the endogenous pluripotency network from the host cell genome finally establishes pluripotent cell characteristics (<xref ref-type="fig" rid="pone-0022413-g006">Fig. 6B</xref>). Finally, the chromatin state of GC/PrM markers may also reflect their transition through germ-cell fate (<xref ref-type="fig" rid="pone-0022413-g006">Fig. 6C</xref>).</p>
      <fig id="pone-0022413-g006" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0022413.g006</object-id>
        <label>Figure 6</label>
        <caption>
          <title>Hypothetical model for the germ cell origin of pluripotent ESCs.</title>
          <p>(<bold>A</bold>) The inner cell mass cells of the blastocyst are positive for Oct3/4 and Sox2 expression. During further development, primordial germ cell (PGC) specification in mouse implantation embryos (blastocyst (∼E3.5) stage onwards) is marked by the expression of germ cell markers Blimp1 and Fragilis followed by reactivation of Oct3/4 and Sox2 and is completed by ∼E6.5-E7.5 <italic>in vivo</italic>. This period of <italic>in vivo</italic> PGC specification parallels with the <italic>in vitro</italic> ESCs generation from pre-implantation blastocysts (∼E3.5) together with 3–5 days of ESCs outgrowth. (<bold>B</bold>) On the other hand, reprogramming of somatic cells to iPS cells using the four Yamanaka factors (Oct3/4, Sox2, Klf4 and c-Myc) leads to the early appearance of germ cell markers followed by the activation of endogenous Oct3/4 and Sox2 and subsequent establishment of pluripotent state. This pattern of gene activation is equivalent to that of PGC specification and ESC establishment as discussed above. (<bold>C</bold>) The active chromatin state of germ cell markers in ESCs might indicate the developmental origin of ESCs from PGCs; the presence of bivalent chromatin at the promoter regions of pre-meiotic genes indicate the poised state for germ line commitment.</p>
        </caption>
        <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.g006" xlink:type="simple"/>
      </fig>
      <p>In summary, we show the expression of GC/PrM markers in all analyzed pluripotent cell types and show parallel but independent maintenance of GC/PrM networks from pluripotent networks. Through our data, we propose a hypothetical model for possible germ-cell origin of ESCs and suggest the plausible transition of somatic cells through germ-cell fate to achieve pluripotency. Further genetic and epigenetic studies aimed at PGC specification during ICM outgrowth may resolve and increase our knowledge of pluripotency.</p>
    </sec>
    <sec id="s5">
      <title>Supporting Information</title>
      <supplementary-material id="pone.0022413.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.s001" xlink:type="simple">
        <label>Figure S1</label>
        <caption>
          <p><bold>Effect of the downregulation of Oct3/4 in ES cells.</bold> (<bold>A</bold>) Real time qPCR demonstrating the down-regulation of <italic>Oct3/4</italic> and the expression profile of other pluripotency markers (<italic>Klf4</italic>, <italic>Nanog</italic>, <italic>Zfp206</italic> and <italic>Lin28</italic>). (<bold>B</bold>) Expression profile of germ cell (<italic>Stella</italic> and <italic>Fragilis</italic>) and pre-meiotic (<italic>Dazl</italic>, <italic>MVH</italic> and <italic>Stra8</italic>) markers in <italic>Oct3/4</italic> down-regulated ESCs. The dotted lines indicate the normalized expression levels of analyzed genes in control siRNA treated cells. The qPCR data of two biological replicates (including three technical replicates each) were calculated and represented as a mean ±SD. Expression levels, which are statistically significant, are indicated with asterisks (***p&lt;0.001).</p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0022413.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.s002" xlink:type="simple">
        <label>Figure S2</label>
        <caption>
          <p><bold>Epigenetic signature of pluripotency and GC/PrM genes in ES cells.</bold> (<bold>A</bold>) Chip-seq data from the database showing that the promoter regions (red box) of pluripotency marker gene <italic>Oct3/4</italic> and germ cell markers <italic>Blimp1</italic> (<italic>Prdm1</italic>), <italic>Stella</italic> (<italic>Dppa3</italic>) and <italic>Fragilis</italic> (<italic>Ifitm3</italic>) representing open chromatin with abundance of active histone modification H3K4me3 (green peaks) and are depleted of repressive marks like H3K27me3 and H3K9me3 (highlighted with red and brown peaks respectively). In contrast, the promoter regions of pre-meiotic genes <italic>MVH</italic> (<italic>Ddx4</italic>), <italic>Dazl</italic>, <italic>Hoxa11</italic> and <italic>Pax5</italic> were marked with both active and repressive histone modification marks, signifying their bivalent chromatin structure (<bold>B</bold>).</p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0022413.s003" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.s003" xlink:type="simple">
        <label>Figure S3</label>
        <caption>
          <p><bold>Histopathological analysis identifies iPS cell-derived tumors as teratomas.</bold> Tumors grown in RAG2<sup>−/−</sup>cγc<sup>−/−</sup> mice after injection of iPS cell lines #xu2 and #xu6 were HE stained. The tumors are teratomas showing ectodermal mesodermal and endodermal differentiations (* skin epithelium, # cartilage, → muscle, ▸ gut epithelium). The scale bar represents 100 µm.</p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0022413.s004" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.s004" xlink:type="simple">
        <label>Table S1</label>
        <caption>
          <p>
            <bold>Primers used in RT-PCR.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0022413.s005" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.s005" xlink:type="simple">
        <label>Table S2</label>
        <caption>
          <p>
            <bold>Quantitative real-time PCR primers for siRNA down regulation study.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0022413.s006" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.s006" xlink:type="simple">
        <label>Table S3</label>
        <caption>
          <p>
            <bold>Quantitative real-time PCR primers used to test endogenous gene expression.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0022413.s007" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.s007" xlink:type="simple">
        <label>Table S4</label>
        <caption>
          <p>
            <bold>List of antibodies used in Western blotting.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0022413.s008" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0022413.s008" xlink:type="simple">
        <label>Table S5</label>
        <caption>
          <p>
            <bold>Quantitative real-time PCR primers used in Chip assay.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors would like to thank Lukasz Smorag and Marieke Wolf for their support and valuable discussions. The authors would like to thank MSC distribution center, Texas A&amp;M health science center for providing mouse MSCs, Prof. Shinya Yamanaka for kindly providing retroviral constructs for iPS cells generation and Dr. Michael Engelke for helping in retroviral transduction experiments.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pone.0022413-Evans1">
        <label>1</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Evans</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Kaufman</surname><given-names>MH</given-names></name></person-group>             <year>1981</year>             <article-title>Establishment in culture of pluripotential cells from mouse embryos.</article-title>             <source>Nature</source>             <volume>292</volume>             <fpage>154</fpage>             <lpage>156</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Martin1">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>GR</given-names></name></person-group>             <year>1981</year>             <article-title>Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>78</volume>             <fpage>7634</fpage>             <lpage>7638</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Matsui1">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Matsui</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zsebo</surname><given-names>K</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>BL</given-names></name></person-group>             <year>1992</year>             <article-title>Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture.</article-title>             <source>Cell</source>             <volume>70</volume>             <fpage>841</fpage>             <lpage>847</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Resnick1">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Resnick</surname><given-names>JL</given-names></name><name name-style="western"><surname>Bixler</surname><given-names>LS</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Donovan</surname><given-names>PJ</given-names></name></person-group>             <year>1992</year>             <article-title>Long-term proliferation of mouse primordial germ cells in culture.</article-title>             <source>Nature</source>             <volume>359</volume>             <fpage>550</fpage>             <lpage>551</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Kahan1">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kahan</surname><given-names>BW</given-names></name><name name-style="western"><surname>Ephrussi</surname><given-names>B</given-names></name></person-group>             <year>1970</year>             <article-title>Developmental potentialities of clonal in vitro cultures of mouse testicular teratoma.</article-title>             <source>J Natl Cancer Inst</source>             <volume>44</volume>             <fpage>1015</fpage>             <lpage>1036</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Guan1">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>K</given-names></name><name name-style="western"><surname>Nayernia</surname><given-names>K</given-names></name><name name-style="western"><surname>Maier</surname><given-names>LS</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>S</given-names></name><name name-style="western"><surname>Dressel</surname><given-names>R</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Pluripotency of spermatogonial stem cells from adult mouse testis.</article-title>             <source>Nature</source>             <volume>440</volume>             <fpage>1199</fpage>             <lpage>1203</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-KanatsuShinohara1">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kanatsu-Shinohara</surname><given-names>M</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>K</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Yoshimoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Ogonuki</surname><given-names>N</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Generation of pluripotent stem cells from neonatal mouse testis.</article-title>             <source>Cell</source>             <volume>119</volume>             <fpage>1001</fpage>             <lpage>1012</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Takahashi1">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Yamanaka</surname><given-names>S</given-names></name></person-group>             <year>2006</year>             <article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.</article-title>             <source>Cell</source>             <volume>126</volume>             <fpage>663</fpage>             <lpage>676</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Zwaka1">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zwaka</surname><given-names>TP</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>JA</given-names></name></person-group>             <year>2005</year>             <article-title>A germ cell origin of embryonic stem cells?</article-title>             <source>Development</source>             <volume>132</volume>             <fpage>227</fpage>             <lpage>233</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Ohinata1">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ohinata</surname><given-names>Y</given-names></name><name name-style="western"><surname>Payer</surname><given-names>B</given-names></name><name name-style="western"><surname>O'Carroll</surname><given-names>D</given-names></name><name name-style="western"><surname>Ancelin</surname><given-names>K</given-names></name><name name-style="western"><surname>Ono</surname><given-names>Y</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Blimp1 is a critical determinant of the germ cell lineage in mice.</article-title>             <source>Nature</source>             <volume>436</volume>             <fpage>207</fpage>             <lpage>213</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Saiti1">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Saiti</surname><given-names>D</given-names></name><name name-style="western"><surname>Lacham-Kaplan</surname><given-names>O</given-names></name></person-group>             <year>2007</year>             <article-title>Mouse Germ Cell Development in-vivo and in-vitro.</article-title>             <source>Biomark Insights</source>             <volume>2</volume>             <fpage>241</fpage>             <lpage>252</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Saitou1">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Saitou</surname><given-names>M</given-names></name><name name-style="western"><surname>Barton</surname><given-names>SC</given-names></name><name name-style="western"><surname>Surani</surname><given-names>MA</given-names></name></person-group>             <year>2002</year>             <article-title>A molecular programme for the specification of germ cell fate in mice.</article-title>             <source>Nature</source>             <volume>418</volume>             <fpage>293</fpage>             <lpage>300</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Sato1">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Sato</surname><given-names>M</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>T</given-names></name><name name-style="western"><surname>Kurokawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Fujita</surname><given-names>Y</given-names></name><name name-style="western"><surname>Abe</surname><given-names>K</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>Identification of PGC7, a new gene expressed specifically in preimplantation embryos and germ cells.</article-title>             <source>Mech Dev</source>             <volume>113</volume>             <fpage>91</fpage>             <lpage>94</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Bowles1">
        <label>14</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bowles</surname><given-names>J</given-names></name><name name-style="western"><surname>Koopman</surname><given-names>P</given-names></name></person-group>             <year>2007</year>             <article-title>Retinoic acid, meiosis and germ cell fate in mammals.</article-title>             <source>Development</source>             <volume>134</volume>             <fpage>3401</fpage>             <lpage>3411</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Geijsen1">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Geijsen</surname><given-names>N</given-names></name><name name-style="western"><surname>Horoschak</surname><given-names>M</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K</given-names></name><name name-style="western"><surname>Gribnau</surname><given-names>J</given-names></name><name name-style="western"><surname>Eggan</surname><given-names>K</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Derivation of embryonic germ cells and male gametes from embryonic stem cells.</article-title>             <source>Nature</source>             <volume>427</volume>             <fpage>148</fpage>             <lpage>154</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Mise1">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mise</surname><given-names>N</given-names></name><name name-style="western"><surname>Fuchikami</surname><given-names>T</given-names></name><name name-style="western"><surname>Sugimoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Kobayakawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Ike</surname><given-names>F</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Differences and similarities in the developmental status of embryo-derived stem cells and primordial germ cells revealed by global expression profiling.</article-title>             <source>Genes Cells</source>             <volume>13</volume>             <fpage>863</fpage>             <lpage>877</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Qing1">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Qing</surname><given-names>T</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qin</surname><given-names>H</given-names></name><name name-style="western"><surname>Ye</surname><given-names>X</given-names></name><name name-style="western"><surname>Wei</surname><given-names>W</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Induction of oocyte-like cells from mouse embryonic stem cells by co-culture with ovarian granulosa cells.</article-title>             <source>Differentiation</source>             <volume>75</volume>             <fpage>902</fpage>             <lpage>911</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Zechner1">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zechner</surname><given-names>U</given-names></name><name name-style="western"><surname>Nolte</surname><given-names>J</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>M</given-names></name><name name-style="western"><surname>Shirneshan</surname><given-names>K</given-names></name><name name-style="western"><surname>Hajj</surname><given-names>NE</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Comparative methylation profiles and telomerase biology of mouse multipotent adult germline stem cells and embryonic stem cells.</article-title>             <source>Mol Hum Reprod</source>             <volume>15</volume>             <fpage>345</fpage>             <lpage>353</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Voss1">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Voss</surname><given-names>AK</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>T</given-names></name><name name-style="western"><surname>Gruss</surname><given-names>P</given-names></name></person-group>             <year>1997</year>             <article-title>Germ line chimeras from female ES cells.</article-title>             <source>Exp Cell Res</source>             <volume>230</volume>             <fpage>45</fpage>             <lpage>49</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Wernig1">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wernig</surname><given-names>M</given-names></name><name name-style="western"><surname>Meissner</surname><given-names>A</given-names></name><name name-style="western"><surname>Foreman</surname><given-names>R</given-names></name><name name-style="western"><surname>Brambrink</surname><given-names>T</given-names></name><name name-style="western"><surname>Ku</surname><given-names>M</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.</article-title>             <source>Nature</source>             <volume>448</volume>             <fpage>318</fpage>             <lpage>324</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Okita1">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Okita</surname><given-names>K</given-names></name><name name-style="western"><surname>Ichisaka</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamanaka</surname><given-names>S</given-names></name></person-group>             <year>2007</year>             <article-title>Generation of germline-competent induced pluripotent stem cells.</article-title>             <source>Nature</source>             <volume>448</volume>             <fpage>313</fpage>             <lpage>317</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Chazaud1">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chazaud</surname><given-names>C</given-names></name><name name-style="western"><surname>Yamanaka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pawson</surname><given-names>T</given-names></name><name name-style="western"><surname>Rossant</surname><given-names>J</given-names></name></person-group>             <year>2006</year>             <article-title>Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK pathway.</article-title>             <source>Dev Cell</source>             <volume>10</volume>             <fpage>615</fpage>             <lpage>624</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Khromov1">
        <label>23</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Khromov</surname><given-names>T</given-names></name><name name-style="western"><surname>Krishna Pantakani</surname><given-names>DV</given-names></name><name name-style="western"><surname>Nolte</surname><given-names>J</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>M</given-names></name><name name-style="western"><surname>Dressel</surname><given-names>R</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Global and gene-specific histone modification profiles of mouse multipotent adult germline stem cells.</article-title>             <publisher-name>Mol Hum Reprod</publisher-name>          </element-citation>
      </ref>
      <ref id="pone.0022413-Dressel1">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dressel</surname><given-names>R</given-names></name><name name-style="western"><surname>Guan</surname><given-names>K</given-names></name><name name-style="western"><surname>Nolte</surname><given-names>J</given-names></name><name name-style="western"><surname>Elsner</surname><given-names>L</given-names></name><name name-style="western"><surname>Monecke</surname><given-names>S</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.</article-title>             <source>Biol Direct</source>             <volume>4</volume>             <fpage>31</fpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Dressel2">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dressel</surname><given-names>R</given-names></name><name name-style="western"><surname>Nolte</surname><given-names>J</given-names></name><name name-style="western"><surname>Elsner</surname><given-names>L</given-names></name><name name-style="western"><surname>Novota</surname><given-names>P</given-names></name><name name-style="western"><surname>Guan</surname><given-names>K</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells.</article-title>             <source>Faseb J</source>             <volume>24</volume>             <fpage>2164</fpage>             <lpage>2177</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Mikkelsen1">
        <label>26</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mikkelsen</surname><given-names>TS</given-names></name><name name-style="western"><surname>Ku</surname><given-names>M</given-names></name><name name-style="western"><surname>Jaffe</surname><given-names>DB</given-names></name><name name-style="western"><surname>Issac</surname><given-names>B</given-names></name><name name-style="western"><surname>Lieberman</surname><given-names>E</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Genome-wide maps of chromatin state in pluripotent and lineage-committed cells.</article-title>             <source>Nature</source>             <volume>448</volume>             <fpage>553</fpage>             <lpage>560</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Nayernia1">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Nayernia</surname><given-names>K</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Drusenheimer</surname><given-names>N</given-names></name><name name-style="western"><surname>Nolte</surname><given-names>J</given-names></name><name name-style="western"><surname>Wulf</surname><given-names>G</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Derivation of male germ cells from bone marrow stem cells.</article-title>             <source>Lab Invest</source>             <volume>86</volume>             <fpage>654</fpage>             <lpage>663</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Carter1">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>MG</given-names></name><name name-style="western"><surname>Sharov</surname><given-names>AA</given-names></name><name name-style="western"><surname>VanBuren</surname><given-names>V</given-names></name><name name-style="western"><surname>Dudekula</surname><given-names>DB</given-names></name><name name-style="western"><surname>Carmack</surname><given-names>CE</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Transcript copy number estimation using a mouse whole-genome oligonucleotide microarray.</article-title>             <source>Genome Biol</source>             <volume>6</volume>             <fpage>R61</fpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Efroni1">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Efroni</surname><given-names>S</given-names></name><name name-style="western"><surname>Duttagupta</surname><given-names>R</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>J</given-names></name><name name-style="western"><surname>Dehghani</surname><given-names>H</given-names></name><name name-style="western"><surname>Hoeppner</surname><given-names>DJ</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Global transcription in pluripotent embryonic stem cells.</article-title>             <source>Cell Stem Cell</source>             <volume>2</volume>             <fpage>437</fpage>             <lpage>447</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Meshorer1">
        <label>30</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Meshorer</surname><given-names>E</given-names></name><name name-style="western"><surname>Misteli</surname><given-names>T</given-names></name></person-group>             <year>2006</year>             <article-title>Chromatin in pluripotent embryonic stem cells and differentiation.</article-title>             <source>Nat Rev Mol Cell Biol</source>             <volume>7</volume>             <fpage>540</fpage>             <lpage>546</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Roeder1">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Roeder</surname><given-names>RG</given-names></name></person-group>             <year>2005</year>             <article-title>Transcriptional regulation and the role of diverse coactivators in animal cells.</article-title>             <source>FEBS Lett</source>             <volume>579</volume>             <fpage>909</fpage>             <lpage>915</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Azuara1">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Azuara</surname><given-names>V</given-names></name><name name-style="western"><surname>Perry</surname><given-names>P</given-names></name><name name-style="western"><surname>Sauer</surname><given-names>S</given-names></name><name name-style="western"><surname>Spivakov</surname><given-names>M</given-names></name><name name-style="western"><surname>Jorgensen</surname><given-names>HF</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Chromatin signatures of pluripotent cell lines.</article-title>             <source>Nat Cell Biol</source>             <volume>8</volume>             <fpage>532</fpage>             <lpage>538</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Bernstein1">
        <label>33</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bernstein</surname><given-names>E</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>EM</given-names></name><name name-style="western"><surname>Masui</surname><given-names>O</given-names></name><name name-style="western"><surname>Gil</surname><given-names>J</given-names></name><name name-style="western"><surname>Heard</surname><given-names>E</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin.</article-title>             <source>Mol Cell Biol</source>             <volume>26</volume>             <fpage>2560</fpage>             <lpage>2569</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Cox1">
        <label>34</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Cox</surname><given-names>JL</given-names></name><name name-style="western"><surname>Rizzino</surname><given-names>A</given-names></name></person-group>             <year>2010</year>             <article-title>Induced pluripotent stem cells: what lies beyond the paradigm shift.</article-title>             <source>Exp Biol Med (Maywood)</source>             <volume>235</volume>             <fpage>148</fpage>             <lpage>158</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Li1">
        <label>35</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Liang</surname><given-names>J</given-names></name><name name-style="western"><surname>Ni</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>T</given-names></name><name name-style="western"><surname>Qing</surname><given-names>X</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts.</article-title>             <source>Cell Stem Cell</source>             <volume>7</volume>             <fpage>51</fpage>             <lpage>63</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-SamavarchiTehrani1">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Samavarchi-Tehrani</surname><given-names>P</given-names></name><name name-style="western"><surname>Golipour</surname><given-names>A</given-names></name><name name-style="western"><surname>David</surname><given-names>L</given-names></name><name name-style="western"><surname>Sung</surname><given-names>HK</given-names></name><name name-style="western"><surname>Beyer</surname><given-names>TA</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming.</article-title>             <source>Cell Stem Cell</source>             <volume>7</volume>             <fpage>64</fpage>             <lpage>77</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Matsui2">
        <label>37</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Matsui</surname><given-names>Y</given-names></name></person-group>             <year>2009</year>             <article-title>The molecular mechanisms regulating germ cell development and potential.</article-title>             <source>J Androl</source>             <volume>31</volume>             <fpage>61</fpage>             <lpage>65</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Saitou2">
        <label>38</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Saitou</surname><given-names>M</given-names></name></person-group>             <year>2009</year>             <article-title>Germ cell specification in mice.</article-title>             <source>Curr Opin Genet Dev</source>             <volume>19</volume>             <fpage>386</fpage>             <lpage>395</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Lawson1">
        <label>39</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lawson</surname><given-names>KA</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>NR</given-names></name><name name-style="western"><surname>Roelen</surname><given-names>BA</given-names></name><name name-style="western"><surname>Zeinstra</surname><given-names>LM</given-names></name><name name-style="western"><surname>Davis</surname><given-names>AM</given-names></name><etal/></person-group>             <year>1999</year>             <article-title>Bmp4 is required for the generation of primordial germ cells in the mouse embryo.</article-title>             <source>Genes Dev</source>             <volume>13</volume>             <fpage>424</fpage>             <lpage>436</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Okamura1">
        <label>40</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Okamura</surname><given-names>D</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakano</surname><given-names>T</given-names></name><name name-style="western"><surname>Matsui</surname><given-names>Y</given-names></name></person-group>             <year>2003</year>             <article-title>Cadherin-mediated cell interaction regulates germ cell determination in mice.</article-title>             <source>Development</source>             <volume>130</volume>             <fpage>6423</fpage>             <lpage>6430</lpage>          </element-citation>
      </ref>
      <ref id="pone.0022413-Ying1">
        <label>41</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ying</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>XM</given-names></name><name name-style="western"><surname>Marble</surname><given-names>A</given-names></name><name name-style="western"><surname>Lawson</surname><given-names>KA</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>GQ</given-names></name></person-group>             <year>2000</year>             <article-title>Requirement of Bmp8b for the generation of primordial germ cells in the mouse.</article-title>             <source>Mol Endocrinol</source>             <volume>14</volume>             <fpage>1053</fpage>             <lpage>1063</lpage>          </element-citation>
      </ref>
    </ref-list>
    
  </back>
</article>